Ligand-based Exosome Affinity Purification (LEAP) Column Chromatography: A Tool for Clinical Applications

2024

Closed access Metadata (CSL-JSON)
DOI 10.18502/wkmj.v66i4.17768
Data confidence 85 high
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Exosomes are nano-sized extracellular vesicles that play essential roles in intercellular communication, carrying biomolecules such as proteins, lipids, and RNAs that can influence physiological and pathological processes. The isolation of pure exosomes is critical for both basic research and clinical applications, including diagnostics and therapeutics. Traditional exosome isolation techniques, such as ultracentrifugation, lack specificity and may yield impure samples, making the need for advanced isolation techniques evident. Ligand-based exosome affinity purification (LEAP) column chromatography has emerged as a novel method that utilizes specific ligands targeting exosome surface markers, providing a highly specific, gentle, and scalable approach to exosome isolation. This mini review explores LEAP chromatography’s mechanism, benefits, and potential for clinical applications, emphasizing its g.rowing importance in exosome-based diagnostics and therapies.